Preclinical research with OmeGo® demonstrates potential to treat eosinophilic asthma
15.05.2020
Two-year research collaboration contract signed with Stanford on the use of Salmon Protein Hydrolysate peptides for the treatment of GI tract diseases in children and adults
11.05.2020
Notice of Annual General Meeting 2020
04.05.2020
SHARE CAPITAL INCREASE REGISTERED
06.04.2020
PRIVATE PLACEMENT TOWARDS BOMI FRAMROZE – PRIMARY INSIDER DISCLOSURE
23.03.2020
EU DISTRIBUTION AGREEMENT SIGNED WITH PRINOVA EUROPE FOR MARINE BRANDED PRODUCTS RANGE
17.03.2020
MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDER IN HOFSETH BIOCARE ASA
26.02.2020
Fourth Quarter 2019 Financial Report
07.02.2020
Signs new working capital credit line of NOK 37m
04.02.2020
MANDATORY NOTIFICATION OF TRADE
01.01.2020